Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Oncology Reports|November 27, 2010
Characteristics of severe adverse events after peptide vaccination for advanced cancer patients: Analysis of 500 casesKazumi Yoshida, Masanori Noguchi, Takashi Mine, et al.
The Prostate|September 21, 2004
Immunological evaluation of individualized peptide vaccination with a low dose of estramustine for HLA-A24+ HRPC patientsMasanori Noguchi, Kyogo Itoh, Akihisa Yao, et al.
Asian Journal of Andrology|December 22, 2007
Effect of an extract of Ganoderma lucidum in men with lower urinary tract symptoms: a double-blind, placebo-controlled randomized and dose-ranging studyMasanori Noguchi, Tatsuyuki Kakuma, Katsuro Tomiyasu, et al.
BJU International|December 21, 2010
A phase I study of personalized peptide vaccination for advanced urothelial carcinoma patients who failed treatment with methotrexate, vinblastine, adriamycin and cisplatinKazumasa Matsumoto, Masanori Noguchi, Takefumi Satoh, et al.
Cancer Science|September 24, 2017
Personalized peptide vaccination as second-line treatment for metastatic upper tract urothelial carcinomaShigetaka Suekane, Kousuke Ueda, Kiyoaki Nishihara, et al.
The Prostate|September 25, 2004
New epitope peptides derived from parathyroid hormone-related protein which have the capacity to induce prostate cancer-reactive cytotoxic T lymphocytes in HLA-A2+ prostate cancer patientsAkihisa Yao, Mamoru Harada, Satoko Matsueda, et al.
Plos One|October 12, 2013
Aldehyde dehydrogenase 1 identifies cells with cancer stem cell-like properties in a human renal cell carcinoma cell lineKosuke Ueda, Sachiko Ogasawara, Jun Akiba, et al.
Cancer Science|October 9, 2007
Phase I trial of personalized peptide vaccination for cytokine-refractory metastatic renal cell carcinoma patientsShigetaka Suekane, Masaaki Nishitani, Masanori Noguchi, et al.
Oncology Reports|June 21, 2013
A phase II study of a personalized peptide vaccination for chemotherapy-resistant advanced pancreatic cancer patientsShigeru Yutani, Nobukazu Komatsu, Munehiro Yoshitomi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 11, 2007
[Acquired tumor "robustness" in the case of prostate cancer]Shigenori Homma, Masanori Noguchi, Yuji Sato, et al.
Pageof 10